PUBLIC COMPANY
saveAvenCell Therapeutics Inc
updated 5mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- In the hunt for reverse merger targets, Caribou could be prized gameThe struggling cell therapy developer is exploring strategic alternatives, which, among other characteristics, make it a likely candidate to receive reverse merger interest.biopharma_dive · 1mo ago
- Doudna’s CAR T biotech Caribou to end R&D activities, slash staff as financing freezes upCaribou Biosciences entered the scene in 2011 and went public in 2021. Over the course of its existence, the biotech has received funding and support from a handful of Big Pharma players, including…biospace · 1mo ago
comments(0)
5-min edit window · permanent after that